, Volume 4, Issue 2, pp 98-107
Date: 19 Jan 2011

Measuring Treatment Effects in Clinical Trials Using Cardiac MRI

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Cardiac MRI (CMR) offers the potential to assess valid and reliable parameters associated with cardiac diseases and the corresponding clinical prognosis. It has therefore emerged as a tool for outcome measures, resulting in lower study sample sizes, shorter duration of clinical studies, and subsequently less trial costs. This review focuses on the theoretical and practical background of CMR in measuring treatment effects in clinical trials.